The iFuse is a minimally invasive surgical system including titanium implants. The implants are coated with a porous plasma spray to regulate and decrease implant motion.
The system is indicated for use by the FDA for fracture fixation of large bones and large bone fractures of the pelvis.
Read the Science 2.0 report about iFuse.
Read other coverage on SI-BONE:
– SI-BONE Closes $11M Financing for Commercial and Clinical Expansion
– SI-BONE Begins Post-Market Clinical Experience of iFuse Implant Device
– SI-BONE Launches iFuse Implant System in Europe
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
